PACTG 219C

PACTG 219C

• 批准号: 7607566
• 负责人: Juan C Salazar
• 金额: $ 5.36万
• 依托单位: UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7607566
• 关键词: AIDS clinical trial group; Child; Clinical; Clinical Data; Computer Retrieval of Information on Scientific Projects Database; Data; Data Collection; Disease Progression; Evaluation; Funding; Grant; HIV; Infant; Institution; Laboratories; Morbidity - disease rate; Mothers; Outcome; Perinatal; Protocols documentation; Quality-of-Life Assessment; Recording of previous events; Research; Research Personnel; Resources; Source; United States National Institutes of Health; mortality; neurocognitive test; prospective; treatment effect; treatment trial

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is a prospective longitudinal data collection for late outcomes (due to Human Immunodeficiency Virus [HIV] disease progression, treatment effects and/or an interaction of the two) and late treatment effects. The study is open to children who have participated in AIDS Clinical Trial Group (ACTG) treatment trials and infants whose mother participated in ACTG perinatal treatment trials. Data collected included history, physical exam, neurocognitive testing, clinical and laboratory evaluations, morbidity, mortality and quality of life assessments at specific intervals. This is a long-term protocol that allows us to collect clinical data indefinitely.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 这项研究是针对晚期结果的前瞻性纵向数据收集（由于人类免疫缺陷病毒[HIV]疾病进展，治疗效果和/或两者的相互作用）和晚期治疗效果。 这项研究向参加AIDS临床试验组（ACTG）治疗试验的儿童和母亲参加ACTG围产期治疗试验的婴儿开放。 收集的数据包括历史，身体检查，神经认知测试，临床和实验室评估，以特定时间间隔的评估，发病率，死亡率和生活质量评估。 这是一个长期协议，使我们能够无限期地收集临床数据。